Cattaneo, Dario
Pasina, Luca
Maggioni, Aldo Pietro
Oreni, Letizia
Conti, Federico
Pezzati, Laura
Casalini, Giacomo
Bonazzetti, Cecilia
Morena, Valentina
Ridolfo, Annalisa
Antinori, Spinello
Gervasoni, Cristina http://orcid.org/0000-0002-4922-6495
Funding for this research was provided by:
Università degli Studi di Milano
Article History
Accepted: 28 January 2021
First Online: 1 March 2021
Declarations
:
: Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement.
: All authors declare no competing interests for the present study. Cristina Gervasoni has received personal fees from MSD, ViiV, Gilead and Jansen Cilag unrelated to this study. Dario Cattaneo has received personal fees from MSD, ViiV, and Jansen Cilag unrelated to this study. Aldo Pietro Maggioni has received personal fees from Bayer, Fresenius, and Novartis for participating in study committees unrelated to this study. Luca Pasina, Letizia Oreni, Federico Conti, Laura Pezzati, Giacomo Casalini, Cecilia Bonazzetti, Valentina Morena, Annalisa Ridolfo, and Spinello Antinori declare they have no potential conflicts of interest.
: This study was approved by the Ethics Committee (Comitato Etico Interaziendale Area 1) at our hospital.
: All patients included in this study signed an informed consent form.
: Not applicable.
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Research design and manuscript first draft: DC, CG. Provision of study materials or patients: FC, LP, GC, CB, VM, AR, SA, CG. Data analysis: DC, LP, APM, and LO. Final manuscript approval: All authors.